WSE:KVT

Stock Analysis Report

Executive Summary

Krynica Vitamin S.A. produces and sells non-alcoholic and low-alcoholic beverages primarily in Poland.

Snowflake

Fundamentals

Undervalued with mediocre balance sheet.

Share Price & News

How has Krynica Vitamin's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

4.5%

KVT

-1.8%

PL Beverage

1.9%

PL Market


1 Year Return

-14.7%

KVT

18.5%

PL Beverage

0.2%

PL Market

Return vs Industry: KVT underperformed the Polish Beverage industry which returned 18.5% over the past year.

Return vs Market: KVT underperformed the Polish Market which returned 0.2% over the past year.


Shareholder returns

KVTIndustryMarket
7 Day4.5%-1.8%1.9%
30 Day10.1%-3.5%0.5%
90 Day14.4%-3.8%-5.7%
1 Year-2.5%-14.7%20.9%18.5%3.3%0.2%
3 Year-44.3%-54.6%12.0%4.9%12.3%4.3%
5 Yearn/a49.4%33.6%0.2%-12.0%

Price Volatility Vs. Market

How volatile is Krynica Vitamin's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Krynica Vitamin undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: KVT (PLN4.69) is trading below our estimate of fair value (PLN74.46)

Significantly Below Fair Value: KVT is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: KVT is good value based on its PE Ratio (9.1x) compared to the Beverage industry average (22.6x).

PE vs Market: KVT is good value based on its PE Ratio (9.1x) compared to the Polish market (10.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate KVT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: KVT is good value based on its PB Ratio (1.1x) compared to the XE Beverage industry average (1.9x).


Next Steps

Future Growth

How is Krynica Vitamin forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

3.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: KVT's forecast earnings growth (3.2% per year) is above the savings rate (2.9%).

Earnings vs Market: KVT's earnings (3.2% per year) are forecast to grow slower than the Polish market (10.6% per year).

High Growth Earnings: KVT's earnings are forecast to grow, but not significantly.

Revenue vs Market: Insufficient data to determine if KVT's revenue is forecast to grow faster than the Polish market.

High Growth Revenue: Insufficient data to determine if KVT's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if KVT's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Krynica Vitamin performed over the past 5 years?

-32.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: KVT's earnings have declined by -32% per year over the past 5 years.

Accelerating Growth: KVT's earnings growth over the past year (30.2%) exceeds its 5-year average (-32% per year).

Earnings vs Industry: KVT earnings growth over the past year (30.2%) exceeded the Beverage industry 3.3%.


Return on Equity

High ROE: KVT's Return on Equity (12.3%) is considered low.


Return on Assets

ROA vs Industry: KVT's Return on Assets is below or equal to the Beverage industry average last year.


Return on Capital Employed

ROCE Improving: KVT's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is Krynica Vitamin's financial position?


Financial Position Analysis

Short Term Liabilities: KVT's short term assets (PLN74.6M) do not cover its short term liabilities (PLN99.1M)

Long Term Liabilities: KVT's short term assets (74.6M) exceeds its long term liabilities (32.2M)


Debt to Equity History and Analysis

Debt Level: KVT's debt to equity ratio (65.9%) is considered high

Reducing Debt: KVT's debt to equity ratio has increased from 47.7% to 65.9% over the past 5 years.

Debt Coverage: KVT's debt is well covered by operating cash flow (90.4%).

Interest Coverage: KVT's interest payments on its debt are well covered by EBIT (60.7x coverage).


Balance Sheet

Inventory Level: KVT has a high level of physical assets or inventory.

Debt Coverage by Assets: KVT's debt is covered by short term assets (assets are 2.192320x debt).


Next Steps

Dividend

What is Krynica Vitamin's current dividend yield, its reliability and sustainability?

14.07%

Current Dividend Yield


Dividend Yield vs Market

company14.1%marketbottom25%2.7%markettop25%7.2%industryaverage2.1%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: KVT's dividend (14.07%) is higher than the bottom 25% of dividend payers in the Polish market (2.73%).

High Dividend: KVT's dividend (14.07%) is in the top 25% of dividend payers in the Polish market (7.24%)

Stable Dividend: KVT has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: KVT has only been paying a dividend for 4 years, and since then payments have fallen.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (127.4%), KVT's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

What is the CEO of Krynica Vitamin's salary, the management and board of directors tenure and is there insider trading?

4.8yrs

Average board tenure


CEO

Piotr Czachorowski 0

4.4yrs

Tenure

zł527,000

Compensation

Mr. Piotr Czachorowski has been the President of the Management Board at Krynica Vitamin S.A. since May 14, 2015 and serves as its Member of Management Board. 


Board Age and Tenure

4.8yrs

Average Tenure

Experienced Board: KVT's board of directors are considered experienced (4.8 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Agnieszka Donica

    Member of Management Board

    • Tenure: 3.8yrs
  • Piotr Czachorowski

    President of The Management Board

    • Tenure: 4.4yrs
    • Compensation: zł527.00k
  • Agata Klepacka

    Chief Accountant

    • Tenure: 0yrs

Board Members

  • Rafal Mania

    Chairman of the Supervisory Board

    • Tenure: 5.5yrs
    • Compensation: zł7.20k
  • Bartosz Czachorowski

    Member of the Supervisory Board

    • Tenure: 6yrs
    • Compensation: zł7.20k
  • Adam Rosz

    Member of the Supervisory Board

    • Tenure: 4.2yrs
    • Compensation: zł7.20k
  • Witold Jesionowski

    Member of the Supervisory Board

    • Tenure: 3.3yrs

Company Information

Krynica Vitamin S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Krynica Vitamin S.A.
  • Ticker: KVT
  • Exchange: WSE
  • Founded: 2011
  • Industry: Soft Drinks
  • Sector: Food, Beverage & Tobacco
  • Market Cap: zł57.461m
  • Shares outstanding: 12.25m
  • Website: https://www.krynicavitamin.com

Location

  • Krynica Vitamin S.A.
  • ul. Matyldy 35
  • Warsaw
  • 03-606
  • Poland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
KVTWSE (Warsaw Stock Exchange)YesBearer SharesPLPLNDec 2015

Biography

Krynica Vitamin S.A. produces and sells non-alcoholic and low-alcoholic beverages primarily in Poland. The company offers basic energy drinks, energy drinks with juice, and natural energy drinks; and vitam ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/22 21:43
End of Day Share Price2019/10/22 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.